Formulation screening and Development

Formulation screening and Development

Acubiosys offers formulation development services to help clients determine optimal dosage levels for new chemical entities (NCE), Generics, Herbal and Ayush therapeutic formulations.

Capabilities

  1. Our strong scientific team has broad experience and expertise in collaborative practices with a global customer base for formulation development services and analytical support.
  2. We cater to pharmaceutical companies worldwide, providing extensive pre-formulation studies, toxicology formulation, formulation development, and analytical method development.
  3. Our formulation development teams offer design and optimization of formulations for powders, capsules, liquids and solids, semi-solids, nasal, nebulizer, pressurized and topical drug formulations.
  4. We provide focused understanding from early stage feasibility to development of new chemical entities (NCE) and generic products.
  5. Prior to pre-clinical studies we can offer a broad range of analytical capabilities including solubility assessment, dissolution, solid state characterization, particle morphology (Malvern Morphology 4 ID), forced degradation and stability screening, in order to select the optimal development candidates.
  6. Our experience in powder characterizationcan drive insight into understanding powder – formulation characteristics whereas our wide range of physical and chemical testing methods can determine particle size (light scattering, microscopy), thermal properties (DSC, TGA), powder rheology, morphology (powder X-ray diffraction), and spectroscopic profiles (FTIR, Raman).
  7. With dedicated teams of highly experienced analysts and specialist formulation and process development scientists, we offer a truly flexible service which will help you develop the optimal formulation.
  • Toxicology formulations for rodent and non rodents
  • Conventional formulations for animal efficacy studies
  • Novel formulations for NCEs, AYUSH and Neutraceuticals to enhance bioavailability and efficacy